TL

the Long Island Emerging technologies Fund (LIETF)

North America, New York, United States, Melville

Description

The LIETF is a collaboration between Topspin Partners, the successor fund to the Long Island Venture Fund

Investor Profile

the Long Island Emerging technologies Fund (LIETF) has made 6 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Seed (50%)
  • Pre Seed (33%)
  • Debt Financing (17%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Health Diagnostics
  • Medical Device
  • Manufacturing
  • Artificial Intelligence (Ai)
  • Bioinformatics
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does the Long Island Emerging technologies Fund (LIETF) frequently co-invest with?

Accelerate Long Island
North America, New York, United States, Melville
Co-Investments: 5
AngelFire Ventures
North America, New York, United States, Mineola
Co-Investments: 1
Long Island Angel Network
North America, New York, United States, Mineola
Co-Investments: 1
Topspin Partners
North America, New York, United States, Mamaroneck
Co-Investments: 1
New York Angels
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by the Long Island Emerging technologies Fund (LIETF)?

DepYmed

Farmingdale, New York, United States

DepYmed is a disease therapeutic development company that develops potent inhibitors of the enzyme PTP1B.

BiotechnologyHealth CareMedical
Pre SeedDec 22, 2015
Amount Raised: $100,000
Symbiotic Health

Roslyn Heights, New York, United States

Symbiotic Health develops transformative microbiome-based therapies to address critical public health challenges.

BiotechnologyHealth CareTherapeuticsWellness
SeedSep 4, 2015
Amount Raised: $500,000
Envisagenics

Long Island City, New York, United States

Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

Artificial Intelligence (AI)BioinformaticsBiotechnologyMachine LearningTherapeutics
Pre SeedJul 29, 2015
Amount Raised: $50,000
SynchroPET

Stony Brook, New York, United States

MRI Compatible Positron Emission Tomography P.E.T. Scanners for human imaging and pre-clinical small animal research.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
SeedJul 7, 2015
Amount Raised: $725,000
Codagenix

Farmingdale, New York, United States

Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.

BiotechnologyGeneticsMedical
SeedDec 16, 2014
Amount Raised: $100,000
Traverse Biosciences

Stony Brook, New York, United States

Traverse Biosciences, Inc. manufactures medicines for dogs. The company was founded in 2013 and is based in Stony Brook, New York.

BiotechnologyManufacturingTherapeutics
Debt FinancingJun 9, 2014
Amount Raised: $100,000